Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/SISRAM-MEDICAL-LTD-39103926/nieuws/Sisram-Medical-Ltd-kondigt-Fase-IIb-klinisch-resultaat-aan-over-submentale-vetvermindering-van-JS-00-40854537/?utm_source=whatsapp&utm_medium=social&utm_campaign=share